ZA952242B - Recombinant viruses their preparation and their use in gene therapy - Google Patents
Recombinant viruses their preparation and their use in gene therapyInfo
- Publication number
- ZA952242B ZA952242B ZA952242A ZA952242A ZA952242B ZA 952242 B ZA952242 B ZA 952242B ZA 952242 A ZA952242 A ZA 952242A ZA 952242 A ZA952242 A ZA 952242A ZA 952242 B ZA952242 B ZA 952242B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- gene therapy
- recombinant viruses
- viruses
- recombinant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factors [FGF]
- C07K14/501—Fibroblast growth factors [FGF] acidic FGF [aFGF]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9403190A FR2717495B1 (fr) | 1994-03-18 | 1994-03-18 | Virus recombinants, préparation et utilisation en thérapie génique. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA952242B true ZA952242B (en) | 1996-01-09 |
Family
ID=9461189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA952242A ZA952242B (en) | 1994-03-18 | 1995-03-17 | Recombinant viruses their preparation and their use in gene therapy |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0750675A1 (xx) |
JP (1) | JPH09510357A (xx) |
AU (1) | AU1896195A (xx) |
CA (1) | CA2184409A1 (xx) |
FR (1) | FR2717495B1 (xx) |
IL (1) | IL112993A (xx) |
WO (1) | WO1995025803A1 (xx) |
ZA (1) | ZA952242B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2188575A1 (en) | 1995-02-28 | 1996-09-06 | H. Kirk Hammond | Gene transfer-mediated angiogenesis therapy |
US5792453A (en) * | 1995-02-28 | 1998-08-11 | The Regents Of The University Of California | Gene transfer-mediated angiogenesis therapy |
FR2792531B1 (fr) * | 1999-04-26 | 2003-01-31 | Aventis Pharma Sa | Utilisation d'adenovirus recombinant defectif comprenant un acide nucleique codant pour un facteur angiogenique pour le traitement de l'hypertension arterielle pulmonaire |
KR20020001846A (ko) * | 1999-04-26 | 2002-01-09 | 추후제출 | 폐순환승압을 치료하기 위한 맥관형성 인자를 암호화 하는핵산을 포함하는 재조합 결손 아데노바이러스의 용도 |
CA2430112C (en) | 2000-11-27 | 2010-07-27 | Dnavec Research Inc. | Paramyxovirus vector encoding angiogenesis gene and use thereof |
US20070134204A1 (en) * | 2005-12-09 | 2007-06-14 | Henrich Cheng | Method for treating nerve injury and vector construct for the same |
WO2009128474A1 (ja) | 2008-04-16 | 2009-10-22 | 財団法人化学及血清療法研究所 | トロンビン固定化生体吸収性シート製剤の製造方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2814529B2 (ja) * | 1989-03-16 | 1998-10-22 | 味の素株式会社 | 虚血性脳障害治療薬 |
NZ241021A (en) * | 1990-12-18 | 1993-12-23 | Amgen Inc | Analogues of acidic fibroblast growth factor and pharmaceutical |
AU3129793A (en) * | 1991-11-08 | 1993-06-07 | General Hospital Corporation, The | Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration |
FR2688514A1 (fr) * | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
CA2145535C (en) * | 1992-09-25 | 2007-07-17 | Axel Kahn | Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
FR2704234B1 (fr) * | 1993-04-22 | 1995-07-21 | Centre Nat Rech Scient | Virus recombinants, preparation et utilisation en therapie genique. |
-
1994
- 1994-03-18 FR FR9403190A patent/FR2717495B1/fr not_active Expired - Fee Related
-
1995
- 1995-03-02 CA CA002184409A patent/CA2184409A1/fr not_active Abandoned
- 1995-03-02 JP JP7524416A patent/JPH09510357A/ja active Pending
- 1995-03-02 AU AU18961/95A patent/AU1896195A/en not_active Abandoned
- 1995-03-02 EP EP95911370A patent/EP0750675A1/fr not_active Withdrawn
- 1995-03-02 WO PCT/FR1995/000249 patent/WO1995025803A1/fr not_active Application Discontinuation
- 1995-03-14 IL IL112993A patent/IL112993A/en not_active IP Right Cessation
- 1995-03-17 ZA ZA952242A patent/ZA952242B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0750675A1 (fr) | 1997-01-02 |
FR2717495A1 (fr) | 1995-09-22 |
WO1995025803A1 (fr) | 1995-09-28 |
CA2184409A1 (fr) | 1995-09-28 |
AU1896195A (en) | 1995-10-09 |
FR2717495B1 (fr) | 1996-04-12 |
JPH09510357A (ja) | 1997-10-21 |
IL112993A (en) | 2006-09-05 |
IL112993A0 (en) | 1995-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL111681A0 (en) | Recombinant viruses and their use in gene therapy | |
ZA951803B (en) | Recombinant viruses their preparation and their therapeutic use | |
ZA952563B (en) | Recombinant viruses their preparation and their use in gene therapy | |
IL115584A0 (en) | Viral vectors and their use in gene therapy | |
AU4032893A (en) | Human papilloma virus genes and their use in gene therapy | |
ZA945012B (en) | Viral vectors and their use in gene therapy | |
IL113844A (en) | N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS | |
HUP9801216A3 (en) | Dna molecules, preparation thereof and use thereof in gene therapy | |
HU9503751D0 (en) | Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection | |
SG54275A1 (en) | Dna coding for decarbamylase improved in thermostability and use thereof | |
ZA949103B (en) | Recombinant viruses and their use in gene therapy | |
ZA956849B (en) | Use of a defective recombinant adenovirus in gene therapy | |
IL117466A0 (en) | Recombinant viruses expressing lecithin-cholesterol acryltransferase and their use in gene therapy | |
GB9419553D0 (en) | Polypeptides and their use in the treatment of auto-immune disease | |
IL112075A0 (en) | Recombinant human thymopoietin proteins, their preparation and their medicinal use | |
ZA952242B (en) | Recombinant viruses their preparation and their use in gene therapy | |
ZA964563B (en) | Isoindole derivatives their preparation and their application in therapy | |
ZA952244B (en) | Recombinant viruses their preparation and their use in gene therapy | |
IL128902A0 (en) | N-(2-benzothiazolyl)-1-piperidineethanamine derivatives their preparation and their use in therapy | |
ZA959904B (en) | Iminooxymethyleneanilides thei preparation and their use | |
FR2725213B1 (fr) | Vecteurs viraux et utilisation en therapie genique | |
IL113725A0 (en) | Preparing recombinant aprotini and its variants | |
ZA952286B (en) | Recombinant viruses their preparation and their use in gene therapy | |
ZA952243B (en) | Recombinant viruses their preparation and their use in gene therapy | |
ZA976547B (en) | Lipid-binding proteins and their therapeutic and diagnostic use |